Neil Bander, MD, Weill Cornell Medical College, New York City, NY, discusses the role of PSMA in the management of prostate cancer and it’s various clinical applications, both in diagnostics and treatment. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.